$2.49T
Total marketcap
$75.53B
Total volume
BTC 50.51%     ETH 15.05%
Dominance

Biotage AB (publ) 0GRP.IL Stock

178.8 SEK {{ price }} 0.817591% {{change_pct}}%
Exchange
IOB
Market Cap
17.48B SEK
LOW - HIGH [24H]
0.0000 - 0.0000 SEK
VOLUME [24H]
405 SEK
{{ volume }}
P/E Ratio
55.52
Earnings per share
3.22 SEK

Biotage AB (publ) Price Chart

Biotage AB (publ) 0GRP.IL Financial and Trading Overview

Biotage AB (publ) stock price 178.8 SEK
Previous Close 159.85 SEK
Open 160.6 SEK
Bid 152 SEK x 0
Ask 168 SEK x 0
Day's Range 159.8 - 160.6 SEK
52 Week Range 115.4 - 225.6 SEK
Volume 804 SEK
Avg. Volume 26.27K SEK
Market Cap 10.68B SEK
Beta (5Y Monthly) 0.724521
PE Ratio (TTM) 44.971912
EPS (TTM) 3.22 SEK
Forward Dividend & Yield 1.6 (1.02%)
Ex-Dividend Date April 28, 2023
1y Target Est N/A

0GRP.IL Valuation Measures

Enterprise Value 10.22B SEK
Trailing P/E 44.971912
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.9311147
Price/Book (mrq) 6.2583065
Enterprise Value/Revenue 6.63
Enterprise Value/EBITDA 30.865

Trading Information

Biotage AB (publ) Stock Price History

Beta (5Y Monthly) 0.724521
52-Week Change -5.55%
S&P500 52-Week Change 20.43%
52 Week High 225.6 SEK
52 Week Low 115.4 SEK
50-Day Moving Average 138.86 SEK
200-Day Moving Average 162.06 SEK

0GRP.IL Share Statistics

Avg. Volume (3 month) 26.27K SEK
Avg. Daily Volume (10-Days) 13.33K SEK
Shares Outstanding 66.71M
Float 65.67M
Short Ratio N/A
% Held by Insiders 0.58%
% Held by Institutions 64.88%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.6
Trailing Annual Dividend Yield 1.00%
5 Year Average Dividend Yield N/A
Payout Ratio 0.4294
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 15.57%
Operating Margin (ttm) 18.17%
Gross Margin 60.15%
EBITDA Margin 21.48%

Management Effectiveness

Return on Assets (ttm) 7.92%
Return on Equity (ttm) 15.27%

Income Statement

Revenue (ttm) 1.54B SEK
Revenue Per Share (ttm) 23.35 SEK
Quarterly Revenue Growth (yoy) -6.50%
Gross Profit (ttm) 948M SEK
EBITDA 331M SEK
Net Income Avi to Common (ttm) 240M SEK
Diluted EPS (ttm) 3.56
Quarterly Earnings Growth (yoy) -39.39%

Balance Sheet

Total Cash (mrq) 426M SEK
Total Cash Per Share (mrq) 6.46 SEK
Total Debt (mrq) 230M SEK
Total Debt/Equity (mrq) 13.63 SEK
Current Ratio (mrq) 2.743
Book Value Per Share (mrq) 25.582

Cash Flow Statement

Operating Cash Flow (ttm) 295M SEK
Levered Free Cash Flow (ttm) 178.98M SEK

Profile of Biotage AB (publ)

Country United Kingdom
State N/A
City Uppsala
Address Box 8
ZIP 751 03
Phone 46 18 56 59 00
Website https://www.biotage.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 516

Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic, environmental protection, food safety, and agriculture, as well as clinical, forensic, and academic laboratories. It operates in 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Q&A For Biotage AB (publ) Stock

What is a current 0GRP.IL stock price?

Biotage AB (publ) 0GRP.IL stock price today per share is 178.8 SEK.

How to purchase Biotage AB (publ) stock?

You can buy 0GRP.IL shares on the IOB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Biotage AB (publ)?

The stock symbol or ticker of Biotage AB (publ) is 0GRP.IL.

Which industry does the Biotage AB (publ) company belong to?

The Biotage AB (publ) industry is Medical Instruments & Supplies.

How many shares does Biotage AB (publ) have in circulation?

The max supply of Biotage AB (publ) shares is 97.77M.

What is Biotage AB (publ) Price to Earnings Ratio (PE Ratio)?

Biotage AB (publ) PE Ratio is 55.52795000 now.

What was Biotage AB (publ) earnings per share over the trailing 12 months (TTM)?

Biotage AB (publ) EPS is 3.22 SEK over the trailing 12 months.

Which sector does the Biotage AB (publ) company belong to?

The Biotage AB (publ) sector is Healthcare.